Medroxyprogesterone Acetate Plus Metformin to Prevent Persistent Endometrial Hyperplasia
OBJECTIVE: To determine the effect of metformin on treatment response in simple endometrial hyperplasia without atypia. STUDY DESIGN: In this study, we identified 134 women with simple endometrial hyperplasia without atypia. Seventy two of these women were administered cylic oral medroxyprogesteron...
Saved in:
Main Authors: | Vakkas Korkmaz, Enis Özkaya, Tuncay Küçüközkan, Fadıl Kara, Yasemin Çekmez, Hilal Korkmaz |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Network
2013-08-01
|
Series: | Gynecology Obstetrics & Reproductive Medicine |
Subjects: | |
Online Access: | https://gorm.com.tr/index.php/GORM/article/view/194 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of Human-originated Medroxyprogesterone Acetate (MPA) as Effective Contraceptive in Domesticated Queens (Felis catus) in Iraq
by: Mushtaq A Alabodi, et al.
Published: (2024-12-01) -
Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data
by: Luyang Su, et al.
Published: (2024-12-01) -
The significance of the immunohistochemical method in diagnosing atypical endometrial polyps as manifestations of localized hyperplasia
by: O.V. Poslavska, et al.
Published: (2024-12-01) -
A risk prediction model for endometrial hyperplasia/endometrial carcinoma in premenopausal women
by: Zhen Li, et al.
Published: (2025-01-01) -
Comparison of Frozen and Final Pathology Results in Patients Operated for Endometrial Hyperplasia
by: Gonca Turker Ergun, et al.
Published: (2024-12-01)